TrialESMO open2026

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.

T Macarulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.